Elsevier

European Journal of Cancer

Volume 45, Issue 16, November 2009, Pages 2743-2748
European Journal of Cancer

Position Paper
The importance of early symptom recognition in the context of early detection and cancer survival

https://doi.org/10.1016/j.ejca.2009.08.009Get rights and content

Abstract

Since there is evidence that stage is an important prognostic factor in cancer, interventions aimed at ‘down-staging’ are part of a comprehensive cancer control approach. Besides organised screening programmes, raising awareness of detectable signs and symptoms is recommended.

A precise definition of early cancer signs and symptoms, however, is lacking and there has also been no systematic review regarding the impact of awareness raising interventions on cancer outcomes.

We reviewed the scientific medical literature to assess the consistency and availability of a definition for early cancer symptoms as well as to assess the impact of early cancer diagnosis on survival. Although early diagnosis is an important factor for cancer survival, other considerations such as the cancer profile of a country, the characteristics of cancer types and the availability of devices for diagnosis should be taken into account in promoting early cancer detection. There is a clear need for research to categorise cancer types according to early symptoms in order to increase comparability of studies in this field and to provide guidance for health personnel in primary care settings in low income regions.

Introduction

Cancers comprise a major part of the global chronic disease burden and increasingly contribute to the mortality in low and middle income countries (LMICs).1 Projections indicate that demographic changes and population growth will result in an increase in cancer deaths from 7.1 million in 2002 to 11.5 million in 2030.2 Worldwide, about one third of all cancers are estimated to be amenable to early detection and potential cure with treatment. Raising awareness in the general population about early symptoms is part of a comprehensive approach to control cancer.3

A large number of cancer patients could be saved from premature death and suffering if they had timely access to early detection programmes and to adequate treatment. In addition to socio-demographic variables such as age and socio-economic status (SES), cancer survival is determined by the availability of health education about cancer symptoms to the public and health care professionals, especially those working in primary care, and the access to appropriate diagnostic tests and effective treatment. Early diagnosis can arise from recognition of symptomatic cancers at an earlier stage, when the cancer is localised to the organ of origin and before it invades the surrounding tissue and thus has a higher potential for cure. Early diagnosis is made in symptomatic patients who can detect the symptoms on their own or by health professionals, e.g. in primary care settings. Organised screening programmes, on the other hand, are aimed at detecting tumours through screening asymptomatic individuals and are defined as a site-specific search for malignancies at a stage prior to that detectable by the patient.4 Currently, screening programmes are recommended for cancers of the breast and cervix.3 Since screening is applied to a presumably asymptomatic population, it is not considered further here.

The main challenge for early diagnosis programmes is the sensitivity and specificity of signs and symptoms. The wide variation of first alarm symptoms has been shown in a study on malignancies of the upper gastrointestinal tract.5 Many types of cancers show no specific symptoms at an early stage and are thus diagnosed at a more advanced disease stage. Colorectal cancer symptoms, for example, can be vague and confused with normal fluctuations in bowel habits experienced by the general population.6, 7, 8 Also, head and neck squamous cell carcinomas present with nonspecific symptoms such as sore throat and neck nodes which are shared with common conditions, namely viral pharyngitis or tonsillitis.9

Section snippets

Early cancer diagnosis and survival

A delay in diagnosis with cancer being detected at a more advanced stage is a negative factor in cancer prognosis. For most cancer types, stage at diagnosis is identified to be one of the most important determinants for patient survival.10, 11, 12 Earlier stage has been linked to better survival of selected cancers such as cancers of the breast,13, 14, 15, 16, 17 cervix,18 lung,14, 15 stomach,15, 19 prostate,20, 21 liver,22 and urinary bladder.14, 23 Differences in melanoma skin cancer survival

Review of clinical definitions for earlier and later signs and symptoms

Although there is an official staging system classifying early and advanced cancer stage,34 the terminology of early and advanced with regard to cancer signs and symptoms is not precise and is used differently by health care providers and in different countries. The manifestation of symptoms listed as suitable for early diagnosis greatly depends on location and nature of the tumour and some are only manifested at an advanced stage of the disease.3

There are few definitions from medical textbooks

Impact of awareness intervention on cancer outcome

Education of the public and health care providers on early cancer signs is part of the early detection approach but there have been few investigations on the impact of awareness campaigns on cancer outcomes. The assessment of a newspaper campaign to raise awareness of faecal blood as a possible sign of colorectal cancer indicated that the campaign would lead to more detection of early colorectal cancer cases since there were a number of neglected faecal bleeders in the population.42 A prostate

Discussion

Early cancer detection is a key part of national comprehensive cancer control and can be promoted in every country.56 However, several considerations have to be taken into account in promoting early cancer diagnosis and there are some limitations to this approach.

First, the effect of early diagnosis is mediated by the stage of disease when definite diagnosis is made and treatment is provided. Early detection may thus be effective due to its association with a limited spread of the tumour at

Conclusion

A reduction in cancer deaths is a health care priority and efforts in down-staging cancer can significantly increase cancer survival for many cancer sites such as of the breast, cervix, skin, oral, prostate, and possibly of the lung, stomach, liver and bladder. However, generally low attention is paid to early diagnosis or the need for cultural-sensitive approaches to early cancer detection which take country-specific priorities, socio-economic differences and the health system context into

Conflict of interest statement

None declared.

References (57)

  • M. Ponz de Leon et al.

    Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a specialized cancer registry

    Dig Liver Dis

    (2000)
  • M. Ramos et al.

    Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer

    Eur J Cancer

    (2008)
  • P. McCulloch et al.

    The effects of an awareness-raising program for patients and primary care physicians on the early detection of gastro-oesophageal cancer

    Surgery

    (2003)
  • I. Jatoi et al.

    Why is breast cancer mortality declining?

    Lancet Oncol

    (2003)
  • K. Strong et al.

    Preventing cancer through tobacco and infection control: how many lives can we save in the next 10 years?

    Eur J Cancer Prev

    (2008)
  • C.D. Mathers et al.

    Projections of global mortality and burden of disease from 2002 to 2030

    PLoS Med

    (2006)
  • World Health Organization

    Cancer control. Knowledge into action. WHO Guide for effective programmes: early detection

    (2007)
  • D.F. Austin et al.

    Cancer symptoms, clinical stage, and survival rates

    Am J Public Health

    (1980)
  • R. Curless et al.

    Comparison of gastrointestinal symptoms in colorectal carcinoma patients and community controls with respect to age

    Gut

    (1994)
  • M. Pitchers et al.

    Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival

    Br J Cancer

    (2006)
  • J. Pontén et al.

    Strategies for global control of cervical cancer

    Int J Cancer

    (1995)
  • N. Summerton

    General practitioners and cancer: primary care oncology needs more research if it is to develop

    BMJ

    (2000)
  • L. Teppo et al.

    Cancer patient survival – patterns, comparisons, trends – a population-based Cancer Registry study in Finland

    Acta Oncol

    (1999)
  • C.L. Carter et al.

    Henson. Relation of tumour size, lymph node status, and survival in 24, 740 breast cancer cases

    Cancer

    (1989)
  • M. Porta et al.

    Influence of “diagnostic delay” upon cancer survival: an analysis of five tumour sites

    J Epidemiol Community Health

    (1991)
  • M. Sant et al.

    Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe

    Int J Cancer

    (2003)
  • P.H. Gann

    Interpreting recent trends in prostate cancer incidence and mortality

    Epidemiology

    (1997)
  • S. Hellsten et al.

    Bladder carcinoma. Long-term survival and late recurrence

    Scand J Urol Nephrol

    (1983)
  • Cited by (67)

    View all citing articles on Scopus
    View full text